Novo Nordisk Pharmatech A/S

Novo Nordisk Pharmatech is a leading global supplier of high-quality ingredients for the biopharmaceutical and pharmaceutical industries. The company has attracted an extensive roster of leading pharmaceutical companies through unsurpassed product quality, manufacturing and quality control, regulatory documentation, precision delivery and a comprehensive risk mitigation strategy.

We were established in 1949, acquired by Novo Nordisk in 1986 and have been part of the pharmaceutical group since then. By delivering excellence at every step – through manufacturing and quality control, precision delivery and a comprehensive risk mitigation strategy – we help our customers keep development on track, production flowing and product supplied to hospitals and patients.

Recombinant insulin
We aim to be the best supplier of insulin for cell culture processes by excelling throughout the supply chain – beginning with the quality of our insulin, which is sourced directly from Novo Nordisk, the world’s largest producer.

Quaternary ammonium compounds (Quats)
We provide only the best and safest ingredients for the pharmaceutical and personal care industries. Ingredients produced according to the highest cGMP standards and backed by complete regulatory documentation.

Company’s Keywords:

quaternary ammonium compounds, recombinant insulin human af, benzalkonium chloride bkc, bac, bak pheur, usp, nf, cetrimide pheur, ctab usp, strong cetrimide solution